Poland· PL-100355763
Ivabradine Anpharm
A ivabradine product containing ivabradinum, registered in Poland by Anpharm Przedsiębiorstwo Farmaceutyczne S.A.. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ivabradine is registered in 19 of 19 countries.
Countries holding a registration under ATC C01EB17 (ivabradine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Ivabradine · ATC C01EB17
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ivabradine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in France to $1.75 in Switzerland — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ivabradine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.75
- ES Spain$1.17
- IT Italy$0.81
- FR France$0.59
The record
At a glance
URPL (Poland)- Active substance
- Ivabradinum
- Manufacturer
- Anpharm Przedsiębiorstwo Farmaceutyczne S.A.
- Country
- Poland (PL)
- ATC code
- C01EB17
- ATC class
- Ivabradine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
2 priced- gtin0590187860078956 szt.PLN 110.74
- gtin0590999126473456 szt.PLN 117.33
- gtin05909991264741
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for ivabradine.
Graded by severity as the source publishes them — 128 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ivabradine · interactions on record
203 records
- 128 severe
- 61 moderate
Most severe, free to view
- ClotrimazoleA01AB18severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
14 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ivabradine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBIXEBRAKrka, d.d., Novo mesto, Novo mesto
- SpainAPREDONAV 7,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGMedochemie Limited
- NetherlandsCorlentor 7,5 mg, filmomhulde tabletLes Laboratoires Servier Industrie
- FranceIVABRADINE ACCORD 7,5 mg, comprimé pelliculéACCORD HEALTHCARE (ESPAGNE)
- ItalyCORLENTORLES LABORATOIRES SERVIER
- United StatesCorlanorAmgen Inc
- SwedenCorlentor 7,5 mg Filmdragerad tablettLes Laboratoires Servier
- BelgiumCorlentor 7.5 mgLes Laboratoires Servier
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Ivabradin Aristo, Ivabradin Genericon
- Belgium · Ivabradine Ab, Ivabradine Krka
- Bulgaria · Апредонав, Биксебра
- Cyprus · Apredonav, Bivelen
- Czechia · Bixebra, Ivabradin Teva
- Germany · Ivabalan, Ivabradin 1 A Pharma
- Denmark · Ivabradin Krka, Ivabradin Medical Valley
- Estonia · Brediwal
- Spain · Apredonav, Ivabradina Alter
- France · Ivabradine Alter, Ivabradine Arrow
- United Kingdom (Northern Ireland) · Ivabradine, Ivabradine Amarox
- Greece · Apredonav, Bravigo
- Croatia · Bixebra
- Hungary · Bravadin, Inevica
- Ireland · Ivabradine Krka, Ivabradine Rowex
- Iceland · Corlentor, Ivabradine Accord
- Italy · Ivabradina Aurobindo, Ivabradina Doc Generici
- Liechtenstein · Corlentor, Ivabradine Accord
- Lithuania · Apredonav, Bixebra
- Latvia · Apredonav, Bixebra
- Malta · Apredonav
- Netherlands · Ivabradine Amarox, Ivabradine Aurobindo
- Norway · Corlentor, Ivabradine Accord
- Portugal · Bluepharma Bluesar, Ivabradina Alter
- Romania · Apredonav, Bixebra
- Sweden · Ivabradin Krka, Ivabradin Medical Valley
- Slovenia · Apredonav, Bixebra
- Slovakia · Bixebra, Ivabradin Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbf032dd-5c9a-4988-8fa7-f9bc56231d4e GET /v1/drugs/cbf032dd-5c9a-4988-8fa7-f9bc56231d4e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "7,5 mg",
"packaging": "Rp ¦ EU/1/15/1041/008 ¦ 111510\n14 tabl.\nRp ¦ EU/1/15/1041/009 ¦ 111511\n28 tabl.\n05909991264734 ¦ Rp ¦ EU/1/15/1041/010 ¦ 111512\n56 tabl.\nRp ¦ EU/1/15/1041/011 ¦ 111513\n84 tabl.\nRp ¦ EU/1/15/1041/012 ¦ 111514\n98 tabl.\nRp ¦ EU/1/15/1041/013 ¦ 111515\n100 tabl.\n05909991264741 ¦ Rp ¦ EU/1/15/1041/014 ¦ 111516\n112 tabl.\n05901878600789 ¦ Rp ¦ EU/1/15/1041/010 ¦ Delfarma Sp. z o.o. ¦ 138289\n56 tabl.",
"substance": "Ivabradinum 7.5 mg",
"common_name": "Ivabradinum",
"pl_product_id": "100355763",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about ivabradine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.